C133H165N39O17S4 — CID 164970966
N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-[3-(4-cyclopropylpiperazin-1-yl)propoxy]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-methylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methylsulfanylbenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-propan-2-ylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide (PubChem CID 164970966) has the molecular formula C133H165N39O17S4 and a molecular weight of 2710.31 g/mol. Its IUPAC name is N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-[3-(4-cyclopropylpiperazin-1-yl)propoxy]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-methylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methylsulfanylbenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-propan-2-ylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide.
| Compound Name | N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-[3-(4-cyclopropylpiperazin-1-yl)propoxy]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-methylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methylsulfanylbenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-propan-2-ylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide |
|---|---|
| PubChem CID | 164970966 |
| Molecular Formula | C133H165N39O17S4 |
| Molecular Weight | 2710.31 g/mol |
| Exact Mass | 2708.21 |
| IUPAC Name | N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-[3-(4-cyclopropylpiperazin-1-yl)propoxy]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-methylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methylsulfanylbenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide;N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-[3-(4-propan-2-ylpiperazin-1-yl)propoxy]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-thiazole-5-carboxamide |
| SMILES | CCc1nc(C)sc1C(=O)Nc1nc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN3CCN(C(C)C)CC3)c21.CCc1nc(C)sc1C(=O)Nc1nc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN3CCN(C4CC4)CC3)c21.CCc1nc(C)sc1C(=O)Nc1nc2cc(C(N)=O)cc(SC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN3CCN(C)CC3)c21 |
| InChI | InChI=1S/C45H55N13O6S.C45H57N13O6S.C43H53N13O5S2/c1-6-31-39(65-27(4)48-31)43(62)52-45-49-32-22-28(40(46)59)24-35(63-5)37(32)56(45)14-8-9-15-57-38-33(50-44(57)51-42(61)34-21-26(3)53-58(34)7-2)23-29(41(47)60)25-36(38)64-20-10-13-54-16-18-55(19-17-54)30-11-12-30;1-8-31-39(65-28(6)48-31)43(62)52-45-49-32-22-29(40(46)59)24-35(63-7)37(32)56(45)14-10-11-15-57-38-33(50-44(57)51-42(61)34-21-27(5)53-58(34)9-2)23-30(41(47)60)25-36(38)64-20-12-13-54-16-18-55(19-17-54)26(3)4;1-7-29-37(63-26(4)46-29)41(60)50-43-48-31-22-28(39(45)58)24-34(62-6)36(31)55(43)14-10-9-13-54-35-30(47-42(54)49-40(59)32-20-25(3)51-56(32)8-2)21-27(38(44)57)23-33(35)61-19-11-12-53-17-15-52(5)16-18-53/h8-9,21-25,30H,6-7,10-20H2,1-5H3,(H2,46,59)(H2,47,60)(H,49,52,62)(H,50,51,61);10-11,21-26H,8-9,12-20H2,1-7H3,(H2,46,59)(H2,47,60)(H,49,52,62)(H,50,51,61);9-10,20-24H,7-8,11-19H2,1-6H3,(H2,44,57)(H2,45,58)(H,47,49,59)(H,48,50,60)/b9-8+;11-10+;10-9+ |
| InChIKey | DCOFIWGUGMHLGU-BBUULOMXSA-N |
| XLogP | 14.69 |
| TPSA | 697.78 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 56 |
| Heavy Atoms | 193 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2710.31 |
| LogP ≤ 5 | 14.69 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 48 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|